{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:42:42Z","timestamp":1776944562155,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jmoldx.2026.01.008","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:22:21Z","timestamp":1771359741000},"page":"393-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-Yield DNA-Based Neurofibromatosis Type 1 Diagnostics Reveal Population-Specific Mutation Landscape in 1917 Koreans"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5382-9830","authenticated-orcid":false,"given":"Jaeryuk","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gu-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soojin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8247-3746","authenticated-orcid":false,"given":"Eul-Ju","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2026.01.008_bib1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0660","article-title":"Health supervision for children with neurofibromatosis type 1","volume":"143","author":"Miller","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136262","article-title":"Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry","volume":"5","author":"Tabata","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0959-437X(95)90053-5","article-title":"Ras signaling and NF1","volume":"5","author":"McCormick","year":"1995","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4161\/cc.3.10.1182","article-title":"Ras\/Raf\/ERK signalling and NF1","volume":"3","author":"Harrisingh","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/labinvest.2016.142","article-title":"The NF1 gene in tumor syndromes and melanoma","volume":"97","author":"Kiuru","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Neurofibromatosis: conference statement","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF1 molecular characterization and neurofibromatosis type I genotype\u2013phenotype correlation: the French experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jmoldx.2010.09.002","article-title":"A highly sensitive genetic protocol to detect NF1 mutations","volume":"13","author":"Carmen","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2016.04.005","article-title":"Comprehensive RNA analysis of the NF1 gene in classically affected NF1 affected individuals meeting NIH criteria has high sensitivity and mutation negative testing is reassuring in isolated cases with pigmentary features only","volume":"7","author":"Evans","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/gtmb.2014.0109","article-title":"The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study","volume":"18","author":"Maruoka","year":"2014","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2018.10.006","article-title":"Phenotypic expression of a spectrum of neurofibromatosis type 1 (NF1) mutations identified through NGS and MLPA","volume":"395","author":"Tsipi","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cge.12187","article-title":"A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands","volume":"85","author":"van Minkelen","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ahg.12272","article-title":"Neurofibromatosis type I: mutation spectrum of NF1 in Spanish patients","volume":"82","author":"Palma Milla","year":"2018","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.22997","article-title":"Recurrent NF1 gene variants and their genotype\/phenotype correlations in patients with neurofibromatosis type I","volume":"61","author":"Riva","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/gcc.20289","article-title":"Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients","volume":"45","author":"Wimmer","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3346\/jkms.2006.21.1.107","article-title":"The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1","volume":"21","author":"Jeong","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib20","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00415-023-12127-w","article-title":"Genotype\u2013phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large Chinese cohort","volume":"271","author":"Zhu","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib21","article-title":"Molecular characterization of NF1 and neurofibromatosis type 1 genotype-phenotype correlations in a Chinese population","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/humu.9446","article-title":"Identification of forty-five novel and twenty-three known NF1 mutations in Chinese patients with neurofibromatosis type 1","volume":"27","author":"Lee","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41439-024-00299-4","article-title":"Genotypes and phenotypes of neurofibromatosis type 1 patients in Japan: a hereditary tumor cohort study","volume":"11","author":"Futagawa","year":"2024","journal-title":"Hum Genom Var"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib26","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41431-021-00959-x","article-title":"The LOVD3 platform: efficient genome-wide sharing of genetic variants","volume":"29","author":"Fokkema","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","article-title":"Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844\u2013848","volume":"102","author":"Koczkowska","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","article-title":"Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype\u2013phenotype correlation","volume":"21","author":"Koczkowska","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.23929","article-title":"Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype\u2013phenotype study in neurofibromatosis type 1","volume":"41","author":"Koczkowska","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype\u2013phenotype correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib31","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/cancers16132406","article-title":"Genotype\u2013phenotype correlation in neurofibromatosis type 1: evidence for a mild phenotype associated with splicing variants leading to in-frame skipping of NF1 exon 24 [19a]","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3345\/cep.2020.00871","article-title":"Neurofibromatosis type I: points to be considered by general pediatricians","volume":"64","author":"Kang","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10689-006-9001-3","article-title":"Molecular diagnosis of neurofibromatosis type 1: 2 years experience","volume":"6","author":"Griffiths","year":"2007","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s10038-019-0695-0","article-title":"Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types","volume":"65","author":"Kang","year":"2020","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41525-021-00258-w","article-title":"Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq","volume":"6","author":"Koster","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2016.04.036","article-title":"Neurofibromatosis type 1 molecular diagnosis: the RNA point of view","volume":"7","author":"Pasmant","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib38","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00439-022-02457-6","article-title":"Genome interpretation using in silico predictors of variant impact","volume":"141","author":"Katsonis","year":"2022","journal-title":"Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ebiom.2018.09.039","article-title":"Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture","volume":"36","author":"Isakov","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141735","article-title":"Functional analysis of mutations in exon 9 of NF1 reveals the presence of several elements regulating splicing","volume":"10","author":"Hern\u00e1ndez-Imaz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9628049","article-title":"Functional assays combined with pre-mRNA-splicing analysis improve variant classification and diagnostics for individuals with neurofibromatosis type 1 and Legius syndrome","volume":"2023","author":"Douben","year":"2023","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib42","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00439-023-02555-z","volume":"142","author":"Koczkowska","year":"2023","journal-title":"Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/jcs.181008","article-title":"Nonsense-mediated mRNA decay in humans at a glance","volume":"129","author":"Kurosaki","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib45","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ejhg.2014.243","article-title":"p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas","volume":"23","author":"Pinna","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41431-021-01015-4","article-title":"Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study","volume":"30","author":"Forde","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng.3469","article-title":"Timing, rates and spectra of human germline mutation","volume":"48","author":"Rahbari","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1073\/pnas.0912629107","article-title":"Rate, molecular spectrum, and consequences of human mutation","volume":"107","author":"Lynch","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib49","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00439-021-02363-3","article-title":"Classification of NF1 microdeletions and its importance for establishing genotype\/phenotype correlations in patients with NF1 microdeletions","volume":"140","author":"Kehrer-Sawatzki","year":"2021","journal-title":"Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.008_bib50","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/s41467-025-57077-1","article-title":"A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations","volume":"16","author":"Safonov","year":"2025","journal-title":"Nat Commun"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826000231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826000231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:03:10Z","timestamp":1776942190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157826000231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525157826000231"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.01.008","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Yield DNA-Based Neurofibromatosis Type 1 Diagnostics Reveal Population-Specific Mutation Landscape in 1917 Koreans","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}